M Lamotte

Summary

Affiliation: IMS Health

Publications

  1. ncbi request reprint A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease
    Mark Lamotte
    Health Economics and Disease Management, Brussels, Belgium
    Pharmacoeconomics 24:155-69. 2006
  2. doi request reprint The cost-utility of dabigatran etexilate compared with warfarin in treatment and extended anticoagulation of acute VTE in the UK
    Anamaria Vera Jugrin
    Mark Lamotte, Medialaan 38, 1800 Vilvoorde, Belgium, Tel 32 2 627 3318, E mail
    Thromb Haemost 114:778-92. 2015
  3. pmc The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma
    Laetitia Gerlier
    Health Economics and Outcomes Research Department, IMS Health Consulting, Medialaan 38, 1800 Vilvoorde, Belgium
    BMC Cancer 10:642. 2010
  4. ncbi request reprint A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction
    Mark Lamotte
    Health Economics and Outcomes Research, Unit of IMS Health, Brussels, Belgium
    Pharmacoeconomics 24:783-95. 2006
  5. ncbi request reprint A health economic evaluation of concomitant surgical ablation for atrial fibrillation
    Mark Lamotte
    IMS Health Economics and Outcomes Research, Brussels, Belgium
    Eur J Cardiothorac Surg 32:702-10. 2007
  6. ncbi request reprint Health economic evaluation of outpatient management of fibromyalgia patients and the costs avoided by diagnosing fibromyalgia in France
    M Lamotte
    IMS Health Consulting, Health Economics and Outcomes Research, Brussels, Belgium
    Clin Exp Rheumatol 28:S64-70. 2010
  7. ncbi request reprint Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin's lymphoma in four European countries
    L Annemans
    Health Economics and Disease Management, Brusselsesteenweg 91, 1860 Meise, Belgium
    Leuk Lymphoma 44:77-83. 2003
  8. doi request reprint Pulmonary artery pressure limits exercise capacity at high altitude
    R Naeije
    Laboratory of Physiology, Faculty of Medicine, Free University, Brussels, Belgium
    Eur Respir J 36:1049-55. 2010

Collaborators

  • Lieven Annemans
  • Henk van den Berg
  • R Pieters
  • Thomas Evers
  • Anamaria Vera Jugrin
  • Laetitia Gerlier
  • R Naeije
  • Anastasia Ustyugova
  • Michael Urbich
  • Tom Sunderland
  • Luc Somers
  • Andre Bosly
  • Nicole Straetmans
  • Veronique Cocquyt
  • D Abramowicz
  • S Neupane
  • K Retailleau
  • Ahmad Awada
  • Yassine Lalami
  • S Huez
  • Christian Focan
  • Jean Pascal Machiels
  • Didier Verhoeven
  • Jeroen Mebis
  • V Faoro
  • St├ęphanie Henry
  • Greet Bries

Detail Information

Publications8

  1. ncbi request reprint A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease
    Mark Lamotte
    Health Economics and Disease Management, Brussels, Belgium
    Pharmacoeconomics 24:155-69. 2006
    ..The primary objective of this study was to assess the economic consequences of the use of low-dose aspirin in the primary prevention of CVD in four European countries (UK, Germany, Spain and Italy)...
  2. doi request reprint The cost-utility of dabigatran etexilate compared with warfarin in treatment and extended anticoagulation of acute VTE in the UK
    Anamaria Vera Jugrin
    Mark Lamotte, Medialaan 38, 1800 Vilvoorde, Belgium, Tel 32 2 627 3318, E mail
    Thromb Haemost 114:778-92. 2015
    ....
  3. pmc The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma
    Laetitia Gerlier
    Health Economics and Outcomes Research Department, IMS Health Consulting, Medialaan 38, 1800 Vilvoorde, Belgium
    BMC Cancer 10:642. 2010
    ..The existence of a medical need for G-CSF primary and secondary prophylaxis with these regimens was investigated in a real-life setting...
  4. ncbi request reprint A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction
    Mark Lamotte
    Health Economics and Outcomes Research, Unit of IMS Health, Brussels, Belgium
    Pharmacoeconomics 24:783-95. 2006
    ..This study assessed the cost effectiveness of adding n-3 PUFAs to the current secondary prevention treatment versus standard prevention alone after acute MI in five countries: Australia, Belgium, Canada, Germany and Poland...
  5. ncbi request reprint A health economic evaluation of concomitant surgical ablation for atrial fibrillation
    Mark Lamotte
    IMS Health Economics and Outcomes Research, Brussels, Belgium
    Eur J Cardiothorac Surg 32:702-10. 2007
    ..g. CABG, valve repair) in comparison with non-interventional (drug) treatment...
  6. ncbi request reprint Health economic evaluation of outpatient management of fibromyalgia patients and the costs avoided by diagnosing fibromyalgia in France
    M Lamotte
    IMS Health Consulting, Health Economics and Outcomes Research, Brussels, Belgium
    Clin Exp Rheumatol 28:S64-70. 2010
    ..To assess whether the decrease in medical resource use and cost after diagnosing fibromyalgia, observed in a large primary care population in the United Kingdom can be extrapolated to France...
  7. ncbi request reprint Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin's lymphoma in four European countries
    L Annemans
    Health Economics and Disease Management, Brusselsesteenweg 91, 1860 Meise, Belgium
    Leuk Lymphoma 44:77-83. 2003
    ..TLS cases incurred 11 times higher costs than HU cases in which TLS was absent. The main cost drivers in TLS are interventions requiring intensive care...
  8. doi request reprint Pulmonary artery pressure limits exercise capacity at high altitude
    R Naeije
    Laboratory of Physiology, Faculty of Medicine, Free University, Brussels, Belgium
    Eur Respir J 36:1049-55. 2010
    ..Selective endothelin A receptor blockade with sitaxsentan improves mild pulmonary hypertension and restores exercise capacity without adverse effects on renal function in hypoxic normal subjects...